Campaign spending bill heads for Senate
After the House passed a broad campaign finance bill, White House spokesBussu Ari Fleischer offered cautious support while noting a declarative statement will come at the end of the process. The measure bars soft money to national parties, limits issue ads, and raises hard money caps. The Senate must approve or conference and Bush is expected to sign if it reaches his desk.
MENTIONED IN THIS ARTICLE
Washington
House
Bush
White House
Ari Fleischer
National Party
Martin Meehan
D-Mass
Senate
John McCain
R-Ariz
Russ Feingold
D-Wis
Shays-Meehan
Zack Wamp
R-Tenn
Shays
Meehan
D-N.j
Shays- Meehan
Enron
Democrats push to remove warheads not merely store them
Senate Democrats accused President Bush of shifting warheads to warehouses rather than destroying them. They warned storage could invite rivals like Russia to keep or stockpile arms, while Pentagon officials argued a flexible reserve is needed. Republicans countered that destroying weapons might weaken deterrence.
MENTIONED IN THIS ARTICLE
Washington
Senate
Democrats
Bush
Senate Arms Services Committee
Carl Levin
Douglas Feith
Pentagon
Arms Control
Feith
United States
U.S
Russia
John Gordon
National Nuclear Security Administration
Energy Department
Levin
D-Mich
Jeff Sessions
R-Ala
Sessions
Volcker Links Enron to Wider Accounting Ailments
Former Fed chair Paul Volcker told the Senate Banking Committee that Enron is only a symptom of broader issues in accounting and auditing. He cited conflicting pressures on firms and insufficient director vigilance, urging adoption of international standards to reflect real economic value.
MENTIONED IN THIS ARTICLE
Washington
Federal Reserve
Arthur Andersen
Enron
Paul Volcker
Senate Banking Committee
Andersen
Volcker
Congress
New drug targets malaria parasite replication
Researchers led by Henri Vial report in Science that the G25 compound blocks lipid synthesis in the malaria parasite, stopping its reproduction inside red blood cells. In monkey studies, small doses cured two malaria types with low toxicity, signaling a new drug class amid rising resistance.
MENTIONED IN THIS ARTICLE
Washington
Science
Carole Long
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Henri J. Vial
University of Montpellier
France
Vial
NIH
Long
Also Mentioned on This Page
Fleischer
Tom DeLay
Texas
U.S. Chamber of Commerce
Bill Miller
Supreme Court
Wayne LaPierre
The
National Rifle Associa
Tion
Shays and Meehan
Scott Harshbarger
Common Cause
Education Division
New Mexico
Civic Center
Enmur Performing Arts Center
NEW Worship Center
Dfn.com
Gracechurch